Clinical Trials Browser

Phase 1 × Arsenic Trioxide × Thoracic × Clear all

NCT02066870 2015-03-13

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung